Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Jan 31;92(3):647–648. doi: 10.1073/pnas.92.3.647

Differentiation and cancer: the conditional autonomy of phenotype.

R G Lynch 1
PMCID: PMC42676  PMID: 7846030

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billadeau D., Ahmann G., Greipp P., Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med. 1993 Sep 1;178(3):1023–1031. doi: 10.1084/jem.178.3.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clinicopathologic conference: Multiple malignancies: chronic lymphocytic leukemia, malignant melanoma, multiple myeloma and acute myelomonocytic leukemia. Am J Med. 1975 Mar;58(3):408–416. doi: 10.1016/0002-9343(75)90607-5. [DOI] [PubMed] [Google Scholar]
  3. Corradini P., Boccadoro M., Voena C., Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J Exp Med. 1993 Sep 1;178(3):1091–1096. doi: 10.1084/jem.178.3.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Foucar K., Rydell R. E. Richter's syndrome in chronic lymphocytic leukemia. Cancer. 1980 Jul 1;46(1):118–134. doi: 10.1002/1097-0142(19800701)46:1<118::aid-cncr2820460120>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  5. Fu S. M., Chiorazzi N., Kunkel H. G. Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev. 1979;48:23–44. doi: 10.1111/j.1600-065x.1979.tb00297.x. [DOI] [PubMed] [Google Scholar]
  6. Goldman R. L., Winterling A. N., Winterling C. C. Maturation of tumors of the sympathetic nervous system. Report of long-term survival in 2 patients, one with disseminated osseous metastases, and review of cases from the literature. Cancer. 1965 Nov;18(11):1510–1516. doi: 10.1002/1097-0142(196511)18:11<1510::aid-cncr2820181124>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  7. Grogan T. M., Durie B. G., Lomen C., Spier C., Wirt D. P., Nagle R., Wilson G. S., Richter L., Vela E., Maxey V. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features. Blood. 1987 Oct;70(4):932–942. [PubMed] [Google Scholar]
  8. Hilbert D. M., Shen M. Y., Rapp U. R., Rudikoff S. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):649–653. doi: 10.1073/pnas.92.3.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kubagawa H., Vogler L. B., Capra J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med. 1979 Oct 1;150(4):792–807. doi: 10.1084/jem.150.4.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Milburn G. L., Lynch R. G. Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC-315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cells. J Exp Med. 1982 Mar 1;155(3):852–862. doi: 10.1084/jem.155.3.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nowell P., Finan J., Glover D., Guerry D. Cytogenetic evidence for the clonal nature of Richter's syndrome. Blood. 1981 Jul;58(1):183–186. [PubMed] [Google Scholar]
  12. Osterborg A., Steinitz M., Lewin N., Bergenbrant S., Holm G., Lefvert A. K., Mellstedt H. Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy. Blood. 1991 Nov 15;78(10):2642–2649. [PubMed] [Google Scholar]
  13. Parslow T. G., Milburn G. L., Lynch R. G., Granner D. K. Suppressor T cell action inhibits the expression of an excluded immunoglobulin gene. Science. 1983 Jun 24;220(4604):1389–1391. doi: 10.1126/science.6222474. [DOI] [PubMed] [Google Scholar]
  14. Rohrer J. W., Lynch R. G. Antigen-specific regulation of myeloma cell differentiation in vivo by carrier-specific T cell factors and macrophages. J Immunol. 1978 Sep;121(3):1066–1074. [PubMed] [Google Scholar]
  15. Rohrer J. W., Lynch R. G. Immunoregulation of localized and disseminated murine myeloma: antigen-specific regulation of MOPC-315 stem cell proliferation and secretory cell differentiation. J Immunol. 1979 Sep;123(3):1083–1087. [PubMed] [Google Scholar]
  16. Rohrer J. W., Odermatt B., Lynch R. G. Idiotype-specific suppression of MOPC-315 IgA secretion in vivo: reversible blockade of secretory myeloma cells by soluble mediators. J Immunol. 1978 Nov;121(5):1799–1807. [PubMed] [Google Scholar]
  17. Rohrer J. W., Vasa K., Lynch R. G. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation. J Immunol. 1977 Sep;119(3):861–866. [PubMed] [Google Scholar]
  18. Van Riet I., Heirman C., Lacor P., De Waele M., Thielemans K., Van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Br J Haematol. 1989 Nov;73(3):289–295. doi: 10.1111/j.1365-2141.1989.tb07742.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES